11 unknown. 11 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Unknown 11 |
| Phase 1 | 3 | Unknown 3 |
Follow Immunitor LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunotherapy of Chronic Kidney Failure V8 - Renal Failure Chronic | Phase 2 | Unknown | Immunitor LLC | 20 | 2020-06-16 | 2020-05-08 |
| Tableted COVID-19 Therapeutic Vaccine V-SARS - Covid19 | Phase 1 / Phase 2 | Unknown | Immunitor LLC | 20 | 2020-05-15 | 2020-05-27 |
| V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer V-Boost - Glioblastoma Multiforme, Glioma of Brain | Phase 2 | Unknown | Immunitor LLC | 20 | 2019-04-16 | 2019-04-17 |
| Open Label Immunotherapy Trial for Breast Cancer V3-MOMMO - Breast Cancer | Phase 2 | Unknown | Immunitor LLC | 20 | 2018-07-01 | 2019-08-30 |
| Open Label Immunotherapy Trial for Ovarian Cancer Tableted vaccine (V3-OVA) containing ovarian cancer antigens - Ovarian Cancer | Phase 2 | Unknown | Immunitor LLC | 20 | 2018-07-01 | 2019-08-30 |
| Immunotherapy of Cervical Cancer With V3-Cervix V3-Cervix - Cervical Cancer | Phase 2 | Unknown | Immunitor LLC | 20 | 2018-07-01 | 2019-08-30 |
| Open Label Immunotherapy of Myoma V3-Myoma - Myoma;Uterus, Fibroid Uterus | Phase 2 | Unknown | Immunitor LLC | 30 | 2018-06-01 | 2018-07-06 |
| Open Label Immunotherapy of Endometriosis V-Endo - Endometriosis | Phase 2 | Unknown | Immunitor LLC | 30 | 2017-10-01 | 2019-04-16 |
| Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer V3-P - Pancreatic Cancer Non-resectable | Phase 1 / Phase 2 | Unknown | Immunitor LLC | 30 | 2017-05-01 | 2019-08-30 |
| Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma Oral therapeutic vaccine V3-X to treat cholangiocarcinoma - Cholangiocarcinoma | Phase 1 / Phase 2 | Unknown | Immunitor LLC | 20 | 2017-02-20 | 2019-08-30 |
| Open Label Trial of Immunotherapy for Advanced Liver Cancer Daily oral dose of hepcortespenlisimut-L - HCC, Liver Cirrhosis | Phase 2 | Unknown | Immunitor LLC | 120 | 2014-09-01 | 2019-08-30 |
Autoimmune Diseases (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · COVID-19 (1) · Cholangiocarcinoma (1) · Coronavirus Infections (1) · Endometriosis (1) · Fibroma (1) · Glioblastoma (1) · Infertility (1) · Inflammation (1) · Leiomyoma (1) · Liver Cirrhosis (1) · Myofibroma (1) · Neoplasms (1)
Mongolia (11) · Canada (1)
Aldar Bourinbaiar, PhD, MD/PhD (3) · Aldar Bourinbayar, MD/PhD (2) · Aldar Bourinbaiar, MD/PhD (1) · Aldar Bourinbayar, PhD, MD/PhD (1) · Allen Bain, PhD (1)